Results 121 to 130 of about 46,157 (226)

Astrocytoma-Specific Prognostic Associations of Amyloid-Related Biological Processes. [PDF]

Pathophysiology
Narvaez Irizarry FY, Porter TR, Ramirez Serrano N, Kucheryavykh LY.   +3 more
europepmc   +1 more source

An Algorithm at the Table at Multidisciplinary Diagnostic Meetings: A Dramaturgical Analysis

Sociology of Health &Illness, Volume 48, Issue 6, July 2026.
ABSTRACT This paper focuses on how a radiological classification algorithm temporarily became part of existing diagnostic deliberations between different medical specialists. It describes a participatory ethnographic case study in which the output of the algorithm was presented by the first author during weekly multidisciplinary neuro‐oncology meetings.
Justien Dingelstad, Francisca Grommé, Claartje ter Hoeven, Iris Wallenburg   +3 more
wiley   +1 more source

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma. [PDF]

Neuro Oncol
Drucker KL, Panda A, Decker PA, Kosel ML, Kollmeyer TM, Burns TC, Maqbool MA, Shafqat S, Suvakov M, Zadeh G, Giannini C, Vaubel R, Raghunathan A, Parney IF, Kizilbash SH, Ida CM, Abyzov A, Lachance DH, Eckel-Passow JE, Jenkins RB.   +19 more
europepmc   +1 more source

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors

Brain Pathology, Volume 36, Issue 4, July 2026.
EGFR gene amplification constitutes a diagnostic hallmark for glioblastoma, IDH‐wildtype (GB, IDH‐WT). Herein, we demonstrated that EGFR IHC is a highly specific and sensitive biomarker for identifying EGFR amplification and should be part of the neuropathologist's routine panel of antibodies.
Arnault Tauziède‐Espariat, Mary Bah, Farah Sassi, Noémie Pucelle, Charlotte Berthaud, Marion Mandoula, Zeina Dababou, Noah Carnes, Leïla Brissez, Lauren Hasty, Euphrasie Servant, Alice Métais, Pascale Varlet   +12 more
wiley   +1 more source

Triple metachronous primary brain tumors: sequential occurrence of astrocytoma, atypical meningioma, and high-grade glioma without radiotherapy exposure. Illustrative case. [PDF]

J Neurosurg Case Lessons
Wang F, Chang M, Yan M, Qiu Y, Wang M, You W, Zhang J, Wang Z.   +7 more
europepmc   +1 more source

Integrated high‐resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34‐mutant reveals universal TP53 abnormalities

Brain Pathology, Volume 36, Issue 4, July 2026.
This integrated high‐resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34‐mutant expands the spectrum of associated genetic changes and underscores the presence of universal TP53 abnormalities at copy number, sequence, and protein expression level, with frequent yet largely unrecognized TP53 copy‐neutral loss of ...
Jorge A. Trejo‐Lopez, Cinthya Zepeda Mendoza, Thomas M. Kollmeyer, Kristen L. Drucker, Vanessa M. Pazdernik, Paul A. Decker, Corinne E. Praska, Jayson Hardcastle, Stephanie Smoley, Matthew Isaacson, Mallika Gandham, Surendra Dasari, Aditya Raghunathan, Caterina Giannini, Gang Zheng, Aaron Wagner, M. Beatriz Lopes, Kar‐Ming A. Fung, JoElle G. Peterson, Andreana L. Rivera, Christopher Rossi, Meggen A. Walsh, Zied Abdullaev, Kenneth Aldape, Martha Quezado, Drew Pratt, Patrick Joseph Cimino, Robert B. Jenkins, Cristiane M. Ida   +28 more
wiley   +1 more source

Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey. [PDF]

J Neurooncol
Lanman TA, Gonzalez Castro LN, Perlow HK, Youssef G, Strowd RE, Milano MT, Kushnirsky M, Bhatia A, Wen PY, Miller JJ, Rich BJ.   +10 more
europepmc   +1 more source

Current and emerging therapies in IDH-mutant glioma. [PDF]

Neurotherapeutics
Nakhate V, Youssef G, Wen PY.
europepmc   +1 more source

MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma‐Initiating Cells via the Canonical NF‐кB Pathway

Cancer Science, Volume 117, Issue 7, Page 1841-1851, July 2026.
MAP 17 is identified as highly expressed in TMZ‐resistant glioblastoma‐initiating cells (GICs). MAP17 enhances GIC proliferation, TMZ resistance, and tumorigenicity through NF‐κB/RELA‐dependent BCL2 upregulation. ABSTRACT Glioblastoma (GBM) is the most common malignant brain tumor in adults.
Shenshen Dou, You Lee Son, Toru Kondo
wiley   +1 more source

High-grade astrocytoma with piloid features: a case report of comprehensive management. [PDF]

Front Oncol
He Q, Wang F, Cao H, Li Z, Sun M.
europepmc   +1 more source